Failure of response to combination therapy of adalimumab and infliximab in a recalcitrant patient of severe psoriasis and major thalassemia: A case report

Mohamad Goldust; Ghasem Rahmatpour Rokni; Mrinal Gupta; Torello Lotti; Marzieh Bathaei

doi:10.1002/ccr3.2696

Failure of response to combination therapy of adalimumab and infliximab in a recalcitrant patient of severe psoriasis and major thalassemia: A case report

Clin Case Rep. 2020 Feb 3;8(3):550-552. doi: 10.1002/ccr3.2696. eCollection 2020 Mar.

Authors

Mohamad Goldust^{1

2

3

4}, Ghasem Rahmatpour Rokni⁵, Mrinal Gupta⁶, Torello Lotti⁷, Marzieh Bathaei¹

Affiliations

¹ Mazandaran University of Medical Sciences Sari Iran.
² University of Rome Guglielmo Marconi Rome Italy.
³ Department of Dermatology University Medical Center Mainz Mainz Germany.
⁴ Department of Dermatology University Hospital Basel Basel Switzerland.
⁵ Department of Dermatology Mazandaran University of Medical Sciences Sari Iran.
⁶ Treatwell Skin Centre Jammu India.
⁷ Department of Dermatology University of Studies Guglielmo Marconi Rome Italy.

Abstract

This is the first case report of combination therapy in psoriasis with underlying thalassemia that failed after months. The relation of thalassemia with severity of psoriasis and response to treatment should be evaluated in more studies.

Keywords: adalimumab; infliximab; major thalassemia; psoriasis.

Publication types

Case Reports